Trial Profile
Pharmacogenomics of weight loss with sibutramine in obese and overweight patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2009
Price :
$35
*
At a glance
- Drugs Sibutramine (Primary)
- Indications Obesity
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 26 Dec 2007 Status changed from recruiting to completed.
- 09 Mar 2007 New trial record.